Chevy Chase Trust
BIO icon

Chevy Chase Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Chevy Chase Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,141
Closed -$3.04M – 629
2024
Q2 		$3.04M Sell
11,141
-453
-4% -$132K 0.01% 535
2024
Q1 		$4.01M Sell
11,594
-98
-0.8% -$32.2K 0.01% 529
2023
Q4 		$3.78M Sell
11,692
-48
-0.4% -$15K 0.01% 529
2023
Q3 		$4.21M Sell
11,740
-539
-4% -$208K 0.02% 504
2023
Q2 		$4.66M Sell
12,279
-233
-2% -$94.8K 0.02% 503
2023
Q1 		$5.99M Buy
12,512
+127
+1% +$59.5K 0.02% 476
2022
Q4 		$5.21M Sell
12,385
-707
-5% -$285K 0.02% 493
2022
Q3 		$5.46M Buy
13,092
+16
+0.1% +$7.98K 0.02% 479
2022
Q2 		$6.47M Buy
13,076
+81
+0.6% +$42.2K 0.03% 466
2022
Q1 		$7.32M Buy
12,995
+37
+0.3% +$22.3K 0.03% 473
2021
Q4 		$9.79M Sell
12,958
-238
-2% -$178K 0.03% 426
2021
Q3 		$9.84M Sell
13,196
-538
-4% -$403K 0.03% 415
2021
Q2 		$8.85M Sell
13,734
-728
-5% -$443K 0.03% 442
2021
Q1 		$8.26M Sell
14,462
-1,033
-7% -$612K 0.03% 456
2020
Q4 		$9.03M Sell
15,495
-365
-2% -$208K 0.03% 428
2020
Q3 		$8.18M Sell
15,860
-1,340
-8% -$679K 0.03% 417
2020
Q2 		$7.77M Buy
+17,200
New +$7.59M 0.03% 422

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Chevy Chase Trust's BIO Position: Q3 2024 in Review

Chevy Chase Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 11,141 shares — an estimated $3.04M sold.

Chevy Chase Trust first reported a position in BIO in Q2 2020 and held it in 17 quarters. The position peaked at $9.84M in Q3 2021. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Chevy Chase Trust reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Chevy Chase Trust sold 11,141 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $3.04M.
  • Chevy Chase Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 17 quarters.
  • Chevy Chase Trust's Bio-Rad Laboratories Class A position peaked at $9.84M in Q3 2021.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Chevy Chase Trust's 13F filing for Q3 2024, filed 14 Nov 2024.